We could not find any results for:
Make sure your spelling is correct or try broadening your search.
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire GAITHERSBURG, Md., April 29, 2024 GAITHERSBURG, Md., April 29, 2024...
Shareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd. PR Newswire NEW YORK, Feb. 16, 2024 NEW YORK, Feb. 16...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 3.5 | 36.8421052632 | 9.5 | 18.4399 | 8.92 | 47145 | 9.93905234 | CS |
260 | 3.5 | 36.8421052632 | 9.5 | 18.4399 | 8.92 | 47145 | 9.93905234 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions